라사질린 단독 치료 후 과다성욕증을 보인 파킨슨병 환자
Hypersexuality Induced by Rasagiline Monotherapy in a Patinet with Parkinson’s Disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Impulse control disorders including hypersexuality occur occasionally in Parkinson’s disease, especially when treated with dopamine agonist. A 62-year-old male with Parkinson’s disease was initially treated with rasagiline monotherapy and presented hypersexuality. After 8 weeks of discontinuation of the drug, his hypersexual behavior was significantly improved. To our knowledge, this is the first reported Asian case of a hypersexuality caused by rasagiline. Our observation emphasizes that patients and caregivers need to be educated on the possibility of hypersexuality resulting from rasagiline.
Abstract
Impulse control disorders including hypersexuality occur occasionally in Parkinson’s disease, especially when treated with dopamine agonist. A 62-year-old male with Parkinson’s disease was initially treated with rasagiline monotherapy and presented hypersexuality. After 8 weeks of discontinuation of the drug, his hypersexual behavior was significantly improved. To our knowledge, this is the first reported Asian case of a hypersexuality caused by rasagiline. Our observation emphasizes that patients and caregivers need to be educated on the possibility of hypersexuality resulting from rasagiline.
참고문헌 (8)
- Voon V, "Medication-related impulse control and repetitive behaviors in Parkinson disease", Arch Neurol, 64, pp.1089~1096 (2007)
- Sáez-Francàs N, "Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease", Neurologia, 31, pp.231~238 (2016)
- Perez-Lloret S, "Safety of rasagiline for the treatment of Parkinson's disease", Expert Opin Drug Saf, 10, pp.633~643 (2011)
- Kim J, "Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease", J Neurol, 260, pp.429~437 (2013)
- Perez-Lloret S, "Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease", Clin Neuropharmacol, 35, pp.261~265 (2012)
- Vitale C, "Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 cases", Parkinsonism Relat Disord, 19, pp.483~484 (2013)
- Reyes D, "Rasagiline induced hypersexuality in Parkinson's disease", J Clin Neurosci, 21, pp.507~508 (2014)
- Simonet C, "Hypersexuality induced by rasagiline in monotherapy in Parkinson's disease", Neurol Sci, 37, pp.1889~1890 (2016)